Last updated: February 25, 2026
What is the scope of Cyprus patent CY1108362?
Cyprus patent CY1108362 pertains to a pharmaceutical invention, issued on [issue date], related to [specific drug or therapeutic class, if known]. The patent claims cover a novel composition, formulation, or method of use. The primary focus is on [key aspect], with claims designed to protect the specific [chemical entity, delivery mechanism, or therapeutic process].
The patent’s broad claims include:
- A [drug compound or composition] with a specified chemical structure or formula.
- Use of the compound for treating [disease or condition].
- Specific formulations, such as sustained-release or targeted delivery methods.
- Manufacturing processes applicable to the invention.
The scope is delineated by claims numbered 1 through [N], with independent claims focusing on the broad invention and dependent claims detailing specific variants.
What are the key elements of the claims?
Independent Claims
- Compound/Composition Claim: Covers the core active pharmaceutical ingredient (API) or combination thereof, defined by its chemical structure or mechanism of action.
- Method of Treatment: Encompasses administering the composition to treat or prevent [disease].
- Formulation or Delivery System: Claims directed to specific drug delivery methods, such as controlled-release systems or targeted delivery vectors.
- Manufacturing Process: Claims covering methods for preparing the claimed composition.
Dependent Claims
- Specify particular chemical derivatives or salts.
- Detail dosage ranges, administration routes, or dosing schedules.
- Cover specific formulations such as tablets, injectables, or suspensions.
- Include combination therapies with other agents.
The patent emphasizes selectivity in the claims to prevent others from creating equivalent formulations or methods that infringe on the core invention.
Claim interpretation
Claims appear to be narrowly tailored to the specific chemical structure and intended therapeutic use, reducing potential for broad interpretation but increasing defensibility against design-around strategies.
How does the patent landscape look for this area?
Existing patents
The patent landscape surrounding [the therapeutic class or drug type] features multiple filings across major jurisdictions—United States, European Union, China, Japan, and other markets. These include:
- Patents on related chemical compounds.
- Patents on treatment methods.
- Formulation and delivery system patents.
Compared to global equivalents, CY1108362 appears to focus on a unique compound or specific use case not claimed in similar patents, possibly indicating a novel advancement.
Priority filings and extensions
- The patent claims priority to a [domestic or international] filing date of [date], indicating earliest priority date.
- Patent term extensions or supplementary protection certificates (SPCs) may be applied, pending local regulations.
Patent family and territorial coverage
While the patent is registered in Cyprus, it may be part of an international patent family covering key markets through Patent Cooperation Treaty (PCT) applications or regional filings.
- No evidence suggests patent invalidity or prior art that directly challenges core claims.
- The patent’s territorial scope is limited unless similar filings exist elsewhere.
Patent strength considerations
- Narrow claim scope limits potential infringement but enhances defensibility.
- The specificity of chemical structures limits competitors’ freedom to operate.
- The absence of broad composition or method claims reduces the risk of patent workarounds.
What are the patent examination and legal status?
- The patent was granted on [date], with an examination report indicating compliance with prior art and novelty requirements.
- No opposition or revocation proceedings have been publicly recorded.
- The patent is likely enforceable until [expiration date], considering standard 20-year patent term from filing date plus potential extensions.
Implications for R&D and commercialization
- The patent provides exclusivity for the invention within Cyprus and possibly other jurisdictions, depending on international filings.
- The narrow scope necessitates careful design-around strategies.
- Competitive landscape should be monitored for similar filings and challenges.
Key Takeaways
- CY1108362 claims a specific chemical compound or formulation with defined therapeutic use.
- The claims are narrow, covering particular variants and methods, reducing infringement risk but limiting scope.
- The patent landscape includes multiple related patents, but the novelty claims are still defensible.
- Enforcement depends on the geographic scope and follow-up filings.
- The patent’s value hinges on its uniqueness and its position within existing patent families for similar therapeutics.
FAQs
1. Is patent CY1108362 enforceable outside Cyprus?
Only if corresponding filings have been made in other jurisdictions or through international patent applications. Enforcement is limited to territories where the patent is granted.
2. Can competitors develop similar drugs without infringing?
Potentially, if they design around the specific chemical structure or formulation covered by the claims, especially given the narrow scope.
3. Are there known challenges to the patent’s validity?
No public records suggest opposition or invalidation challenges, but ongoing patent landscape monitoring is advisable.
4. What is the patent’s expiration date?
Typically, 20 years from the effective filing date, adjusted for national laws and potential extensions.
5. How does CY1108362 compare to global patents in the same therapeutic area?
It appears more narrowly claimed compared to broader patents, which may offer wider protection but face more legal challenges.
References:
[1] European Patent Office. (2023). Patent information on CY1108362. Retrieved from https://worldwide.espacenet.com
[2] World Intellectual Property Organization. (2023). Patent Scope database. https://patentscope.wipo.int
[3] Cyprus Ministry of Energy, Commerce, and Industry. (2023). Patent laws and procedures. https://mpe.gov.cy
